About Us

Early research in 1889 by Sharmanov T.S.H. in the Ural Mountains had proven that the consumption of mares’s milk can be beneficial to the human body. The research however had not been taken seriously by western medical practitioners as it had been considered to come from The Iron Curtain country. The therapy is called Koumisstherapy, where the processed mares’ milk is prescribed to patients for treatment of peptic ulcer, tuberculosis and chronic hepatitis. In the 1960’s Koumisstherapy had been expanded to various major cities in Russia, including Moscow, Leningrad, Volinsk and 20 other hospitals in major Russian cities.

Further research was carried out by Italians, French and American ( Cornell University of United States) had carried similar research with positive results.
Research and development that was carried out on mares milk had proven that it’s composition is closer to mother’s milk compared to other animals. (Kalaila et. al 1951).
There are a few unique features of the mares’ milk which can be linked for human unique for of fat, carbohydrates and proteins. (Dolaroli et. al 1995).

In Malaysia, an effort by local company, Setia Brothers Sdn. Bhd. a joint collaboration research had been carried out by Universiti Putra Malaysia, Universiti Sains Malaysia, Universiti Malaya and Veterinary Research Institute (VRI) on Niemans Wild Mares' Milk.
The raw material for the product comes from our own Niemans® wild mares' milk. Therefore the raw material is unique and has no identical therapeutic properties between other breed in South East Asia region and rest of the world to date.

The Wild Mares' Milk used by the company is unique when compared to other mares' milk in the sense that it is derived from mares that lives in the wild on an island and consuming a variety of herbs and grass. The wild mares milk had been proven to have special therapeutic healing capabilities. Niemans® products are made after extensive research by local universities and had special therapeutic characteristics.  Setia Brothers Sdn. Bhd. offers a unique equine's based product backed by a reputable R & D program done by a Local Research Universities .

We has a mission to develop and establish a biotechnology base Research and Development Centre mainly to continuously explore the uniqueness of this product's potential in providing treatment/remedy to certain illnesses.

Setia Brothers Sdn. Bhd. (Setia Brothers) is the pioneer company that has been involved in production and R&D program of the wild mares' milk. The R&D program was conducted since November 1995 with the assistance and guidance by Local Universities and government agencies such as:

  • Universiti Putra Malaysia (UPM)
  • Verinary Services (DVSDepartment of Veterinary Services (DVS)
  • Research Institute (VRI)
  • Ministry of International Trade and Industries (MITI)
  • Institute of Medical Research (IMR) and
  • Malaysian Agricultural Research and Development Institute (MARDI)

The programs were intended to determine and to explore the potential therapeutic value that lays within the wild mare's milk unique proteins toward certain chronic illnesses namely cancer and leukemia.


This had been the core activity of the company for the past 12 years. We have already developed   the Wild Mare’s Milk  into a brand with “ Niemans® ” trademark and has since been marketed in capsule form. To date there is no research done anywhere in the world regarding the probability of using mare’s milk as a treatment for chronic illnesses such as cancer and leukemia. Activities like promotions are another form of our marketing strategies. Exposures are good for our line of products to be recognized by the consumer.


Contact Us

Our Headquarter

No. 52-1,Jalan 2A/27A Seksyen 1,Wangsa Maju Setapak 53300 Kuala Lumpur, Wilayah Persekutuan,Malaysia.
Contact Us Tel : 03.4142.7958 / 03.4143.8749  Fax : 03.4143.8749

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

This e-mail address is being protected from spambots. You need JavaScript enabled to view it